287410 — Jeisys Medical Balance Sheet
0.000.00%
HealthcareSpeculativeMid Cap
- KR₩961bn
- KR₩952bn
- KR₩143bn
Annual balance sheet for Jeisys Medical, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 8,221 | 8,235 | 34,291 | 39,583 | 48,830 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 98.4 | 80.9 | 7,402 | 10,916 | 15,575 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 8,320 | 8,316 | 54,173 | 74,483 | 90,510 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | — | 10,750 | 22,140 | 34,660 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 8,320 | 8,316 | 74,059 | 118,118 | 142,313 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.292 | 0.239 | 24,027 | 26,583 | 23,519 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 617 | 633 | 26,973 | 38,700 | 47,306 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 7,703 | 7,682 | 47,086 | 79,418 | 95,006 |
Total Liabilities & Shareholders' Equity | 8,320 | 8,316 | 74,059 | 118,118 | 142,313 |
Total Common Shares Outstanding |